Sergey V. Shmelkov

7.5k total citations · 1 hit paper
25 papers, 2.9k citations indexed

About

Sergey V. Shmelkov is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sergey V. Shmelkov has authored 25 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sergey V. Shmelkov's work include Angiogenesis and VEGF in Cancer (7 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Nerve injury and regeneration (3 papers). Sergey V. Shmelkov is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Nerve injury and regeneration (3 papers). Sergey V. Shmelkov collaborates with scholars based in United States, Portugal and Finland. Sergey V. Shmelkov's co-authors include Shahin Rafii, Ryan St Clair, David Lyden, Andrea T. Hooper, Nicholas W. Gale, David M. Valenzuela, Andrew Murphy, George D. Yancopoulos, Sérgio Dias and George Lam and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Sergey V. Shmelkov

25 papers receiving 2.8k citations

Hit Papers

CD133 expression is not restricted to stem cells, and bot... 2008 2026 2014 2020 2008 200 400 600

Peers

Sergey V. Shmelkov
Till Milde Germany
Lieve Umans Belgium
Andrew Wood United States
Barbara A. Christy United States
Ricardo Martínez United States
R. Maki United States
Roderick T. Bronson United States
Till Milde Germany
Sergey V. Shmelkov
Citations per year, relative to Sergey V. Shmelkov Sergey V. Shmelkov (= 1×) peers Till Milde

Countries citing papers authored by Sergey V. Shmelkov

Since Specialization
Citations

This map shows the geographic impact of Sergey V. Shmelkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey V. Shmelkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey V. Shmelkov more than expected).

Fields of papers citing papers by Sergey V. Shmelkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey V. Shmelkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey V. Shmelkov. The network helps show where Sergey V. Shmelkov may publish in the future.

Co-authorship network of co-authors of Sergey V. Shmelkov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey V. Shmelkov. A scholar is included among the top collaborators of Sergey V. Shmelkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey V. Shmelkov. Sergey V. Shmelkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felsövályi, Klára, et al.. (2018). Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues. Psychopharmacology. 235(9). 2643–2650. 5 indexed citations
2.
Cardozo, Timothy, Evgeny Shmelkov, Klára Felsövályi, et al.. (2017). Chemistry-based molecular signature underlying the atypia of clozapine. Translational Psychiatry. 7(2). e1036–e1036. 13 indexed citations
3.
Song, Minseok, Carol A. Mathews, S. Evelyn Stewart, et al.. (2017). Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder. PLoS ONE. 12(1). e0169994–e0169994. 23 indexed citations
4.
Shmelkov, Evgeny, et al.. (2015). Historeceptomic Fingerprints for Drug-Like Compounds. Frontiers in Physiology. 6. 371–371. 10 indexed citations
5.
Song, Minseok, Joanna Giza, Catia C. Proenca, et al.. (2015). Slitrk5 Mediates BDNF-Dependent TrkB Receptor Trafficking and Signaling. Developmental Cell. 33(6). 690–702. 72 indexed citations
6.
Proenca, Catia C., Peng Gao, Sergey V. Shmelkov, Shahin Rafii, & Francis S. Lee. (2011). Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends in Neurosciences. 34(3). 143–153. 73 indexed citations
7.
Shmelkov, Sergey V., Adı́lia Hormigo, Deqiang Jing, et al.. (2010). Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice. Nature Medicine. 16(5). 598–602. 258 indexed citations
8.
Seandel, Marco, Ilaria Falciatori, Sergey V. Shmelkov, et al.. (2008). Niche players: Spermatogonial progenitors marked by GPR125. Cell Cycle. 7(2). 135–140. 22 indexed citations
9.
Shmelkov, Sergey V., Jason M. Butler, Andrea T. Hooper, et al.. (2008). CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors. Journal of Clinical Investigation. 118(6). 2111–20. 731 indexed citations breakdown →
10.
Seandel, Marco, Jason M. Butler, Hideki Kobayashi, et al.. (2008). Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proceedings of the National Academy of Sciences. 105(49). 19288–19293. 111 indexed citations
11.
Kopp, Hans‐Georg, Andrea T. Hooper, Sergey V. Shmelkov, & Shahin Rafii. (2007). Beta-galactosidase staining on bone marrow. The osteoclast pitfall.. PubMed. 22(9). 971–6. 67 indexed citations
12.
Seandel, Marco, Daylon James, Sergey V. Shmelkov, et al.. (2007). Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature. 449(7160). 346–350. 320 indexed citations
13.
Karajannis, Matthias A., Loı̈c Vincent, Sergey V. Shmelkov, et al.. (2006). Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells. Leukemia. 20(6). 979–986. 46 indexed citations
14.
Kopp, Hans‐Georg, Scott T. Avecilla, Andrea T. Hooper, et al.. (2005). Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood. 106(2). 505–513. 98 indexed citations
15.
Akiri, Gal, Dong Jin, Sergey V. Shmelkov, et al.. (2005). VEGF receptor expression on reactive breast cancer stroma: paving the way for tumor invasion. Journal of Clinical Oncology. 23(16_suppl). 9642–9642. 4 indexed citations
16.
Shmelkov, Sergey V., Ryan St Clair, David Lyden, & Shahin Rafii. (2004). AC133/CD133/Prominin-1. The International Journal of Biochemistry & Cell Biology. 37(4). 715–719. 301 indexed citations
17.
Rafii, Shahin, Scott T. Avecilla, Sergey V. Shmelkov, et al.. (2003). Angiogenic Factors Reconstitute Hematopoiesis by Recruiting Stem Cells from Bone Marrow Microenvironment. Annals of the New York Academy of Sciences. 996(1). 49–60. 112 indexed citations
18.
Shmelkov, Sergey V., Ryan St Clair, Deirdre McGarrigle, et al.. (2003). Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood. 103(6). 2055–2061. 133 indexed citations
19.
Dias, Sérgio, Sergey V. Shmelkov, George Lam, & Shahin Rafii. (2002). VEGF165 promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood. 99(7). 2532–2540. 213 indexed citations
20.
Shmelkov, Sergey V., Jan Visser, & A. V. Belyavsky. (2001). Two-Dimensional Gene Expression Fingerprinting. Analytical Biochemistry. 290(1). 26–35. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026